Accessibility Menu
National Health Investors Stock Quote

National Health Investors (NYSE: NHI)

$75.46
(0.8%)
+0.62
Price as of October 22, 2025, 3:34 p.m. ET

KEY DATA POINTS

Current Price
$75.46
Daily Change
(0.8%) +$0.62
Day's Range
$74.62 - $75.86
Previous Close
$74.84
Open
$75
Beta
0.50
Volume
88,233
Average Volume
214,138
Market Cap
3.6B
Market Cap / Employee
$74.84M
52wk Range
$65.13 - $82.32
Revenue
-
Gross Margin
0.62%
Dividend Yield
4.84%
EPS
$3.13
CAPs Rating
-
Industry
Health Care REITs

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

National Health Investors Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
NHI+5.31%+77.1%+12.11%+4,033%
S&P+15.06%+95.03%+14.29%+1,688%

National Health Investors Company Info

National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$91.39M6.6%
Gross Profit$57.43M5.9%
Gross Margin62.85%-0.4%
Market Cap$3.27B11.3%
Market Cap / Employee$109.14M0.0%
Employees3015.4%
Net Income$36.69M5.0%
EBITDA$71.71M6.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$18.64M26.2%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$868.84M-18.1%
Short Term Debt$250.00M231.5%

Ratios

Q2 2025YOY Change
Return On Assets5.53%0.4%
Return On Invested Capital5.38%0.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$58.72M0.8%
Operating Free Cash Flow$61.34M0.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings28.9222.2123.4422.39-2.99%
Price to Book2.932.452.472.30-2.57%
Price to Sales11.149.319.809.344.12%
Price to Tangible Book Value2.932.452.472.30-2.57%
Price to Free Cash Flow TTM102.5987.6484.9687.7121.12%
Enterprise Value to EBITDA74.1363.6765.5561.371.32%
Free Cash Flow Yield1.0%1.1%1.2%1.1%-17.44%
Return on Equity10.2%10.5%10.6%10.5%3.36%
Total Debt$1.14B$1.15B$1.26B$1.12B-1.51%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.